Pleural Dynamics today announced positive results from a prospective, multicenter study evaluating its ACES device.
Pleural Dynamics, Inc. today announced positive results from a prospective, multicenter study evaluating its Automatic ...
CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN). This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.
The FDA has cleared Becton Dickinson’s catheter system for the treatment of non-malignant, recurrent causes of pleural effusion, or the collection of fluid next to the lungs. This clearance expanded ...
MINNEAPOLIS--(BUSINESS WIRE)--Pleural Dynamics, a medical device company that is building solutions for recurrent fluid collections in the body, announced today that the final patient in “The ACES™ ...
TOKYO & AUSTIN, Texas--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd, (“Taiho”) and Lung Therapeutics, Inc. (“Lung Tx”) announced today an exclusive license agreement of LTI-01, a recombinant human ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For the ...
Please provide your email address to receive an email when new articles are posted on . The average health care cost per patient in the indwelling pleural catheter (IPC) group was $40,179 vs. $46,640 ...
Lung Therapeutics has raised a $36 million series C round to take a treatment for a serious complication of pneumonia through phase 2 studies. Texas-based Lung Therapeutics is built on the research of ...
IT is the unfortunate lot of some patients dying of metastatic cancer of the breast, lung, cervix and so forth to be plagued by severe dyspnea due to recurrent malignant pleural effusions. Many of ...
Pleural effusions complicate end-stage liver disease in 5% of patients. [5,6] Effusions (defined as 500 mL or more of fluid within the pleural space) are typically right-sided. [7,8] No ...